Most researchers looking for CJC-1295 in Baro rapidly learn that local retail options are virtually absent. What this means for Baro researchers is that geography is secondary to your ability to verify analytical documentation — and those verification methods are within reach of all serious researchers. What genuinely separates top CJC-1295 vendors is full COA coverage: HPLC for purity, mass spec for identity and weight verification, and endotoxin testing for safety documentation. Use this guide to verify vendor quality systematically — the framework here work regardless of your location.
How CJC-1295 Works — Mechanisms & Research
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: CJC-1295 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Baro comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
How to Source CJC-1295 — Vendor Guide
Quality CJC-1295 sourcing begins with a useful first test: does this vendor share complete COA data without being asked? Suppliers that publish proactively are operating transparently. When reviewing a CJC-1295 COA, verify: the batch number corresponds to your vial, HPLC purity is ≥98%, mass spec establishes identity, and endotoxin levels are within acceptable research limits. Community reputation in research forums is a complementary signal to COA verification — vendors with sustained positive community feedback have built their reputation on real product performance. Bacteriostatic water is the standard reconstitution medium for CJC-1295 — it contains 0.9% benzyl alcohol that inhibits bacterial growth and extends reconstituted shelf life to 4 weeks when kept refrigerated.
Order CJC-1295 — ships to Baro
COA-verified · International tracking · Research grade
CJC-1295 is sold for research purposes only and is not approved for human consumption by the FDA or equivalent regulatory bodies — all information here is for educational purposes only. Temperature excursions — even short periods above −20°C — can partially degrade CJC-1295 without visible changes; always verify cold chain was maintained during shipping. Verify the endotoxin level in your CJC-1295 batch COA before use in any in-vivo protocol — look for results stated as EU/mg and confirm they fall within appropriate thresholds. Protocol documentation — documenting product details, dates, and administration precisely — is a fundamental research principle that makes anomalous results interpretable.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
